Children’s Hospital Admissions Reduced After March 2020
Fewer hospital admissions reported for respiratory, severe invasive, and vaccine-preventable infections
Vaccine Effectiveness Against Symptomatic COVID-19 Wanes
But protection against COVID-19 hospitalization, death after two doses of BNT162b2 or CHAdOx1-S is more durable
Physician’s Briefing Weekly Coronavirus Roundup
COVID-19 Proning Teams Benefit From Wound Care Specialist Nurse
Findings show inclusion significantly cuts odds of pressure injuries in patients hospitalized with severe COVID-19
Racial, Ethnic Disparities Seen in mAb Treatment for COVID-19
Monoclonal antibody treatment used infrequently among all racial, ethnic groups; Hispanics received mAbs less often than non-Hispanics
Cardiac Outcomes Good for Children With COVID-19-Related MIS-C
All deformation parameters on echocardiogram recovered within first week, including LV global longitudinal strain, peak left atrial strain
AI Model May Predict COVID-19 Outcomes for Critically Ill
Machine learning model incorporates data from 14 proteins derived from a single blood sample to predict survival in patients with COVID-19
BNT162b2 Vaccine Effective Against Severe COVID-19 in Adolescents
Two doses highly effective against COVID-19-related hospitalization and critical illness for those aged 12 to 18 years
AAN Position Statement Addresses Consent Issues in Acute Stroke
Inability to fulfill elements of decisional capacity coupled with need for rapid treatment decisions complicates consent
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19
